This report analyzes the European market for Breast Biopsy Devices in US$ Million. Annual Forecasts are provided for the period 2007 through 2015. Also, a six-year historic analysis is provided for the market. The report profiles 25 companies including many key and niche players such as C. R. Bard Inc., Bard Biopsy Systems, Cardinal Health, Inc., Ethicon Endo-Surgery, Inc., GE Healthcare, Hologic, Inc., iCAD, Inc., Intact Medical Corporation, Koninklijke Philips Electronics N.V., Rubicor Medical, Inc., Sanarus Technologies, SenoRx, Inc., and Siemens AG. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

I.Introduction, Methodology & Product Definitions
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
II. A European Market Report
1.Industry Overview
- A Prelude
- Market Opportunity
- Breast Cancer: A Common Malignancy among Females in The Western World
- Increased Instances of Breast Cancer in Younger Women!
- European Biopsy Devices Market
- Widespread Adoption of Advanced Diagnostic Systems Will Increase Demand for Breast Biopsy Devices
- Key Statistics:
- Table 1: Worldwide Breast Cancer Incidence Rates & Mortality Rate (per 100,000 Persons) for The Year 2007 (Includes Corresponding Graph/Chart)
- Table 2: Percentage of Five-Year Survival Rate for Breast Cancer by Cancer Stage (Includes Corresponding Graph/Chart)
- Competitive Scenario:
- Current Market Conditions
- Impact of Recession
- Key Market Trends & Issues: A Review
- Continuous Fight against Cancer: A Key Propeller for Growth
- Population Aging Makes Rise of Cancer Diagnostics Inevitable
- Table 3: Probability of Developing Breast Cancer by Age Group
- Table 4: Probability of Surviving Breast Cancer by Age Group (Includes Corresponding Graph/Chart)
- Table 5: Population over 65 Years and above in North America, Western Europe and Eastern Europe for The Year 2007 (in Millions) (Includes Corresponding Graph/Chart)
- Promising Developments in Breast Cancer Diagnosis Underway
- Needle Biopsy Score over Open Biopsy
- Widespread Awareness among Patients & Practitioners: The Need of The Hour
- Rise in Use of Breast Markers
- Rise in Use of Mri Guided Breast Biopsy
- Government Breast Cancer Screening Programs Drive Biopsy Devices Market
- Rise in Use of Single Insertion Breast Biopsy Needle
- Roll out of Integrated Breast Centers
- Vacuum-Assisted Biopsy Gain Physician Preference
- Table 6: Reimbursement Benefits for Vacuum-Assisted over Core Needle Biopsy in Office Based Setting in The US Market for The Year 2007
- Reimbursement & Price Sensitivity: Key Challenges for Breast Biopsy Market
- Susceptibility to Radiation Exposure May Hinder Growth
- Competing Solutions May Limit Need of Breast Biopsy Procedures
- High Costs of Biopsy Markers May Constrain Growth
- Pricing Factors
- Technology Innovations in Breast Care Management:
- Breast Thermography - An Alternative to Mammography
- Advanced Mri Technique May Limit Breast Biopsies in Women
- Identification of New Genes May Improve Breast Cancer Diagnosis
- Innovative Mri Technique Identifies Cancerous Breast Tumors
2.Regional Perspective
- Europe
- Market Overview
- Changing Physician Preferences Shape Breast Biopsy Market
- Market Restraints
- Key Statistics:
- Table 7: Top Three Cancers among Europeans for The Year 2006 (Includes Corresponding Graph/Chart)
- Table 8: European Age-Standardised Rate (Asr) for Breast Cancer Incidence per 100, 000 Individuals, by Country, for The Year 2006 (Includes Corresponding Graph/Chart)
- Table 9: European Age-Standardised Rate (Asr) for Breast Cancer Mortality per 100, 000 Individuals, by Country, for The Year 2006 (Includes Corresponding Graph/Chart)
- Germany
- Italy
- Table 10: Female Breast Cancer Cases in Italy (2005): Breakdown of Mortality, Incidence and Prevalence by Number of Cases for Key Italian Regions (Includes Corresponding Graph/Chart)
- United Kingdom
- Role of Government
- Key Statistics:
- Table 11: Percentage Share Breakdown of Common Causes of Female Cancer Deaths in The UK for The Year 2007 (Includes Corresponding Graph/Chart)
- Table 12: Breakdown of New Breast Cancer Cases Diagnosed in The UK by Gender for The Year 2006 (Includes Corresponding Graph/Chart)
- Table 13: Breakdown of Breast Cancer Mortality in The UK by Gender for The Year 2007 (Includes Corresponding Graph/Chart)
- Other Western Nations: Facts & Figures
- United States
- Key Statistics:
- Table 14: Breast Cancer in The United States: Breakdown of Incidence Rate by Ethnic Group for The Year 2007
- Table 15: Breast Cancer in The United States: Breakdown of Mortality Rate by Ethnic Group for The Year 2007
- Table 16: Breakdown of Number of Breast Biopsy Procedures in The United States for The Years 2008 & 2013 (Number of Procedures in 000s) (Includes Corresponding Graph/Chart)
- Table 17: US Breast Biopsy Devices Market (2008): Percentage Share Breakdown of Revenues by Key Players (Includes Corresponding Graph/Chart)
- Table 18: US Vaccuum-Assisted Breast Biopsy Disposables Market (2007): Percentage Share Breakdown of Revenues by Key Players (Includes Corresponding Graph/Chart)
- Table 19: US Vaccuum-Assisted Biopsy Procedures (2007): Percentage Share Breakdown by Procedures Type (Includes Corresponding Graph/Chart)
- Table 20: US Biopsy Products Market (2008): Percentage Share Breakdown of Revenues by Product Segment (Includes Corresponding Graph/Chart)
- Canada
- Table 21: New Breast Cancer-Related Diagnosis in Canada (2007): Percentage Share Breakdown of Female Breast Cancer Incidence by Age Group (Includes Corresponding Graph/Chart)
- Table 22: Breast Cancer-Related Deaths in Canada (2007): Percentage Share Breakdown of Female Breast Cancer Related Death by Age Group (Includes Corresponding Graph/Chart)
3.Product Overview
- Breast Cancer
- Risk Factors
- Breast Cancer Screening
- Breast Cancer Diagnosis
- Breast Biopsy
- Breast Biopsy Procedures
- Surgical Biopsy
- Needle Biopsy
- Fine Needle Aspiration
- Core Needle Biopsy
- Vacuum-Assisted Biopsy
- Commonly Used Breast Biopsy Devices
- Spring Loaded Biopsy Needle
- Vacuum-Assisted Core Biopsy Device
- Minimally Invasive Breast Biopsy (Mibb) Device
- Advanced Breast Biopsy Instrumentation (Abbi) Device
- Mammotome
- Advances in Breast Imaging Techniques
- Ultrasound Image Guidance
- Stereotactic Image Guidance
- Magnetic Resonance Imaging
- Mammotome® Breast Biopsy System
- Digital Spot-View Mammography Enhances Breast Biopsy
- Biopsy Tissue Markers
4.Product Innovations/Introductions
- Senorx Unveils New Model of Senosonix System
- Senorx to Release Starchmark™
- Senorx Unveils Encor®
- Siemens Healthcare Launches New Biopsy Device
5.Recent Industry Activity
- Terason Enters into Agreement with Senorx
- Senorx Receives Ce Mark Rights for Contura™ Mlb
- Revmed Inks A Global License with Spd
- Sanarus Technologies Acquires Sanarus Medical
- Hologic Obtains Ce Mark Approval for Celero®
- Echoserve, Senorx Enter into Co-Promotion Deal
- Naviscan Receives Fda's Approval for Stereo Navigator™
- Volcano Acquires Novelis
- Senorx Receives Ce Mark Approval for Senosonix
- Hologic Completes Merger with Cytyc Corporation
6.Focus on Select Players
- C. R. Bard Inc. (USA)
- Bard Biopsy Systems (USA)
- Cardinal Health, Inc. (USA)
- Ethicon Endo-Surgery, Inc (USA)
- Ge Healthcare (UK)
- Hologic, Inc. (USA)
- Icad, Inc. (USA)
- Intact Medical Corporation (USA)
- Koninklijke Philips Electronics N.V. (The Netherlands)
- Rubicor Medical, Inc., (USA)
- Sanarus Technologies, Llc (USA)
- Senorx, Inc (USA)
- Siemens Ag (Germany)
7.Global Market Perspective
- Table 23: European Recent past, Current & Future Analysis for Breast Biopsy Devices with Annual Sales Figures in US$ Million for Years 2007 through 2015 (Includes Corresponding Graph/Chart)
- Table 24: European Historic Review for Breast Biopsy Devices with Annual Sales Figures in US$ Million for Years 2001 through 2006 (Includes Corresponding Graph/Chart)
- III. Competitive Landscape
- Total Companies Profiled: 25 (Including Divisions/Subsidiaries - 31)
- Region/Countryplayers
- The United States
- Japan
- Europe
- Germany
- The United Kingdom
- Italy
- Rest of Europe
- Middle-East

Pharmaceutical Market Research

Breast Biopsy Devices

Breast Biopsy Devices

Contents

Related products